ST.27-legal status data

The legal status information displayed below is based on WIPO Standard ST.27 and of a purely informative nature. Binding information on the status of the IP right is only available in DPMAregister (Show details).

DE file number: 60 2013 075 332.6, EP file number: 13 86 6337.2, WO file number: PCT/US2013/076051 (Designation/title: GLYCANMODIFIZIERTE ANTI-CD4-ANTIKÖRPER FÜR HIV-PRÄVENTION UND -THERAPIE)

↩ Details

Tabular representation
Current state: Active, Current state: Grant

Key event history
No. Key Event Code Key Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q10 Document published Jun 26, 2014Jun 26, 2014 unchanged
2 Q10 Document published Oct 28, 2015Oct 28, 2015 Filing
3 Q10 Document published Dec 10, 2015Dec 10, 2015Dec 10, 2015 Filing
4 Q10 Document published Jan 13, 2021Jan 13, 2021 Examination
5 Q10 Document published Jan 28, 2021Jan 28, 2021Jan 28, 2021 Examination
6 F10 IP right granted Oct 14, 2021Oct 14, 2021Dec 30, 2021 Grant
7 R10 Party data changed Sep 17, 2024Sep 17, 2024 Grant
Detailed event history
No. Detailed Event Code Detailed Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q12 Application published Jun 26, 2014Jun 26, 2014 unchanged
2 Q12 Application published Oct 28, 2015Oct 28, 2015 Filing
3 Q10 Document published Dec 10, 2015Dec 10, 2015Dec 10, 2015 Filing
4 P22 Classification modified Jun 26, 2020Jun 26, 2020 Filing
5 Q10 Document published Jan 13, 2021Jan 13, 2021 Examination
6 Q10 Document published Jan 28, 2021Jan 28, 2021Jan 28, 2021 Examination
7 F10 IP right granted Oct 14, 2021Oct 14, 2021Dec 30, 2021 Grant
8 R17 Change to representative recorded Sep 17, 2024Sep 17, 2024 Grant

Graphical representation

Below you will see a simplified graphical representation of the legal status information, which is based on WIPO Standard ST.27 using the "Overall Patent/SPC Prosecution Model" defined therein.

Graphical representation of the ST.27 legal status data